Statements in antidepressant advertisements advancing general or comparative efficacy in depression treatment, or professing monoamine theories.

1Number of ads containing claims or theories/number of ads found in breach by the IGM/NBL for this, e.g. 16 unique ads professed general efficacy claims; zero were found to be in violation for this. 2Percentage of ads containing claims or theories of total, e.g. 12.9% of 124 unique advertisements professed general efficacy claims. 3Percentage of ads found in breach by the IGM/NBL of ads containing claims or theories, e.g. 16 unique ads professed general efficacy claims; zero percent were found to be in violation for this. 4Italicized statements were found to breach the code by the IGM/NBL. Case number in the IGM/NBL database is indicated.